Discover more of our free reports coverage from other companies within the Biotechnology industry. Pro-TD has currently selected FibroGen, Inc. (NASDAQ: FGEN) for due-diligence and potential coverage ...
LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it received a new Abbreviated New Drug Application ...
Data presented in a Late Breaking Science session at the 74th Annual Meeting of the American Academy of Dermatology (AAD) in Washington, D.C. demonstrate that ...
Akorn, a leading specialty pharmaceutical company, has received the Food and Drug Administration’s clearance for betamethasone dipropionate lotion (augmented), 0.05%. Betamethasone dipropionate lotion ...
Glenmark Pharmaceuticals, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for clotrimazole and betamethasone dipropionate cream USP, one per ...
It is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older Dr Reddy’s Labs has announced that its US subsidiary, Promius Pharma, launched Sernivo ...
A surge in Indian overnight indexed swap (OIS) rates — typically a key barometer of policy rate expectations in normal times — is overstating the likely impact of the Iran war and higher oil prices on ...
Combination of Generics : Betamethasone Dipropionate 0.05% + Gentamicin 0.1% + Zinc Sulphate 2.5%w/w For the above reasons, Medindia cannot be held liable for any action taken based on the information ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s announced today that its US subsidiary, Promius Pharma TM, LLC, U.S. (BSE: 500124, NSE: DRREDDY ...
Dr. Reddy's announced that Promius Pharma has received approval for Sernivo (betamethasone dipropionate) Spray 0.05% for the treatment of mild to moderate plaque psoriasis in patients aged ≥18 years.
Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results